2m 2m 2m 2m 2m 2m 2m
MANNKIND (MNKD)
NASDAQ
$3.82-$0.13 (-3.29%)
Price as of Oct 02, 2026 6:26 PM EDT- $1.3BMarket Cap
- -28.05%1-Year Change
- BiotechnologyIndustry
MANNKIND (MNKD)
$3.82-$0.13 (-3.29%)
MNKD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.95 | ||
Change | +$0.05 (+1.28%) | ||
Open | $3.84 | ||
High | $4.22 | ||
Low | $3.83 | ||
Previous Close | $3.90 | ||
Volume | 10,190,767 | ||
30-Day Average Volume | 4,920,934 | ||
1-Week Change | 20.06% | ||
1-Month Change | -0.75% | ||
1-Year Change | -28.05% | ||
3-Year Change | -4.36% | ||
5-Year Change | -12.61% | ||
Fundamentals | |||
Shares Outstanding | 321.5M | ||
Total Assets | $732.3M | ||
Market Cap | $1.3B | ||
Enterprise Value | $1.6B | ||
Period: QTR TTM FY | |||
Revenue | $42.0M | ||
Net Income | -$19.0M | ||
Free Cash Flow | -$23.5M | ||
EBIT | -$4.3M | ||
EBITDA | $2.1M | ||
Net Working Capital | $102.8M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | 757 | ||
Enterprise Value/Revenue | 37 | ||
P/B | -19 | ||
P/E | -66 | ||
PEG | 3 | ||
Price/Free Cash Flow | -54 | ||
Price/Operating Cash Flow | -69 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 5 | ||
Last Split Date | 03/03/2017 | ||
Earnings & Revenue